Clincosm LogoSign in Get a demo

uveitis

Showing 1 - 25 of 176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relevance and Efficiency of SecOnd Line Workup for Uveitis

Not yet recruiting
  • Uveitis
  • second line investigations for uveitis etiological workup
  • (no location specified)
Oct 25, 2023

Pediatric Uveitis Patients

Not yet recruiting
  • Uveitis
    • Assiut, Egypt
    • +1 more
    Oct 1, 2023

    The Cohort Study of Uveitis Patients

    Not yet recruiting
    • Uveitis
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      Feb 3, 2023

      Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)

      Active, not recruiting
      • Eye Diseases
      • Uveitis
      • Abatacept 125 MG/ML Prefilled Syringe
      • Leuven, Vlaams-Brabant, Belgium
        UZLeuven
      Jan 26, 2023

      Uveitis Trial in Sohag (Humira)

      Recruiting
      • Uveitis
      • Sohag, Egypt
        Sohag university
      Jan 4, 2023

      Uveitis Trial in United States (Izokibep, Placebo)

      Recruiting
      • Uveitis
      • Phoenix, Arizona
      • +20 more
      Jan 11, 2023

      Uveitis, Lymphoma, NK-Cell Lymphoma Trial in Lyon (Blood sample)

      Recruiting
      • Uveitis
      • +2 more
      • Blood sample
      • Lyon, France
      • +1 more
      Dec 23, 2022

      Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

      Active, not recruiting
      • Uveitis
      • +2 more
      • Sham Injector
      • FAI Insert
      • Waltham, Massachusetts
        EyePoint Study Site
      Dec 20, 2022

      Uveitis Trial in Worldwide (Baricitinib, Adalimumab)

      Recruiting
      • Uveitis
      • Nîmes, Gard, France
      • +22 more
      Nov 9, 2022

      Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)

      Terminated
      • Uveitis
      • +3 more
      • intravitreal injection of Conbercept
      • Beijing, Beijing, China
        Peking Union Medical College Hospital (PUMCH)
      Oct 24, 2022

      YUTIQ® 0.18 mg Intravitreal Implant for Management of Chronic

      Recruiting
      • Uveitis
      • YUTIQ
      • Tianjin, Tianjin, China
        Tianjin Medical University Eye Hospital
      Oct 23, 2022

      Biomarkers in Ocular Inflammation and Uveitis

      Enrolling by invitation
      • Uveitis
      • Ocular Inflammation
        • Bethesda, Maryland
          National Eye Institute (NEI)
        Aug 24, 2022

        Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

        Not yet recruiting
        • Uveitis
        • +3 more
        • Yutiq 0.18 MG Drug Implant
        • Sham Injection
        • Plano, Texas
          Texas Retina Associates
        Aug 3, 2022

        Minocycline, Uveitis, Retinal Degeneration Trial in Guangzhou (minocycline)

        Recruiting
        • Minocycline
        • +2 more
        • Guangzhou, Guangdong, China
          Zhongshan Ophthalmic Center
        Jul 24, 2022

        Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)

        Active, not recruiting
        • Uveitis
        • Los Angeles, California
        • +3 more
        Jul 18, 2022

        Uveitis, Infectious Disease Trial in San Francisco (Metagenomic Deep Sequencing (MDS), Standard of Care (SOC))

        Recruiting
        • Uveitis
        • Infectious Disease
        • Metagenomic Deep Sequencing (MDS)
        • Standard of Care (SOC)
        • San Francisco, California
          University of California San Francisco (UCSF)
        Jul 5, 2022

        Uveitis Trial in Durham (hand-held swept source optical coherence tomography)

        Completed
        • Uveitis
        • hand-held swept source optical coherence tomography
        • Durham, North Carolina
          Duke University Medical Center
        Jun 22, 2022

        Uveitis Trial in Worldwide (Adalimumab (ADA), Conventional immunosuppression (CON))

        Recruiting
        • Uveitis
        • Adalimumab (ADA)
        • Conventional immunosuppression (CON)
        • Los Angeles, California
        • +27 more
        Jun 16, 2022

        Uveitis Trial in United Kingdom

        Recruiting
        • Uveitis
          • Belfast, United Kingdom
          • +30 more
          May 19, 2022

          Methotrexate and Azathioprine as Background Treatment for

          Not yet recruiting
          • Uveitis
            • Brest, France
              CHU de Brest
            May 10, 2022

            Uveitis, Metformin, Glucocorticoid Trial in Tianjin (Metformin, Placebo)

            Recruiting
            • Uveitis
            • +2 more
            • Tianjin, Tianjin, China
              Tianjin Medical University Eye Hospital
            May 5, 2022

            Imaging of Uveitis Patients Receiving Injectable Fluocinolone

            Recruiting
            • Uveitis
            • Fluocinolone Acetonide
            • Cleveland, Ohio
              Cole Eye Institute Cleveland Clinic Foundation
            Apr 27, 2022

            Anterior Chamber Inflammation by Optical Coherence Tomography

            Recruiting
            • Uveitis
              • Cleveland, Ohio
                Cole Eye Institute
              Apr 27, 2022

              Uveitis With Biologic Drugs in Resistant Cases

              Not yet recruiting
              • Uveitis
              • Biologic drugs
              • (no location specified)
              Apr 21, 2022

              Uveitis, Cataract, Inflammation Trial in Mölndal (Hydrophobic IOL: Vivinex (HOYA), Hydrophilic IOL: INCISE (Bausch+Lomb))

              Active, not recruiting
              • Uveitis
              • +3 more
              • Hydrophobic IOL: Vivinex (HOYA)
              • Hydrophilic IOL: INCISE (Bausch+Lomb)
              • Mölndal, Sweden
                Vastra Gotaland Region, Sahlgrenska University Hospital, Departm
              Apr 26, 2022